The Japan Contraceptive Devices Market size was valued at USD 845 Million in 2023 and the total Japan Contraceptive Devices revenue is expected to grow at a CAGR of 7.5% from 2023 to 2030, reaching nearly USD 1401.9 Million in 2030.Japan Contraceptive Devices Overview
The comprehensive report researches the dynamic landscape of Japan's contraceptive devices market, offering a detailed analysis and strategic insights for stakeholders. It investigates the nuanced trends, drivers, challenges, and opportunities prevalent in the sector. Utilizing a meticulous methodology combining primary and secondary research, the report unveils complex market dynamics, consumer behaviors, regulatory frameworks, and competitive landscapes specific to contraceptive devices within Japan.• The estimated 190 million of the 1.9 billion women of reproductive age globally (i.e. those aged 15 to 49 years) want to avoid pregnancy but do not use any method of contraception.
Anchored within the context of Japan's healthcare system, it scrutinizes the infrastructure, insurance mechanisms, and pivotal factors influencing access to and acceptance of contraceptive devices. Additionally, a detailed examination of population demographics interlinked with contraceptive behaviors unveils the evolving trends in family planning, shedding light on shifting attitudes and lifestyles that mold the demand for diverse contraceptive options. Crucially, the report dissects the regulatory framework governing contraceptive devices in Japan, dissecting approval processes, standards, and compliance requisites, thereby assessing their profound impact on market entry and innovative product development. The executive summary provides a comprehensive preview, encapsulating multifaceted insights into market dynamics, healthcare nuances, demographic influences, and regulatory frameworks crucial to Japan's contraceptive devices market landscape. The report offers a holistic view of the Japanese contraceptive devices market in 2023.To know about the Research Methodology :- Request Free Sample ReportJapan Contraceptive Devices Market Dynamics:
Rising Demand For Long-term –Term Contraceptives Surges As Changing Lifestyles Reshape Family Planning Priorities Changing lifestyles, characterized by delayed marriages, career-focused priorities, urbanization, and evolving societal norms, are a significant driver in the Japan contraceptive devices market. The shift in lifestyle choices has led to increased demand for contraceptive solutions that align with these changing priorities, which boosts the Japan contraceptive device market. Individuals are seeking long-term, adaptable, and convenient contraceptive options, reflecting the need for products that accommodate delayed family planning and support career-oriented lifestyles. The driver prompts the market to offer more flexible and long-acting contraceptive devices, catering to the evolving needs and preferences of a demographic delaying traditional life milestones and increasing demand for the japan contraceptive devices industry. 1. The Japanese national health insurance does not cover the cost of emergency contraceptives, which range from $115 to $153 per dose. 2. MMR study analyzed a 25% increase in the adoption of long-term contraceptives among urban, career-focused individuals compared to a decade ago. Vital Role In Helping Demographic Challenges And Healthcare Strain The declining birthrate in Japan has contributed significantly to the country's demographic shift, leading to an aging population. By 2040, projections indicate that approximately 35% of Japan's populace will be over 65 years old, creating a unique societal challenge known as the "Year 2040 problem." This demographic imbalance forecasts a strain on the labor force, with each older adult potentially relying on the support of 1.5 working-age individuals. Additionally, the increasing number of elderly citizens, especially those aged 85 and above, will result in a surge in healthcare demands, potentially surpassing the available medical resources. The Ministry of Health, Labour and Welfare of Japan estimates that by 2040, medical expenses could skyrocket to 66.7 trillion yen, a stark contrast to the 39.2 trillion yen recorded in 2018. In response to these looming challenges, the government has initiated the active promotion of self-medication practices. The advancement and accessibility of contraceptive devices play a crucial role in this landscape by providing individuals with options for family planning and birth control, contributing positively to the declining birth rate and potentially mitigating some of the projected strains on the healthcare system boosting the Japan contraceptive device market. Additionally, by allowing individuals to plan parenthood responsibly, contraceptives indirectly support economic stability by encouraging workforce participation and family planning strategies.Table:- Japan Contraceptive Devices Market Trends Supporting With Real-Time Data
Trends Real-Time Example Impact on Market Impact on People Shift Towards LARCs Increasing usage of hormonal implants and IUDs Increased efficacy, convenience, and long-term effectiveness leading to higher adoption rates According to MMR analysis, around 40% of contraceptive users in Japan prefer LARCs in 2023 thanks to their reliability and ease of use Technological Innovations Fertility tracking apps and smart birth control Development of more sophisticated and user-friendly devices, attracting tech-savvy consumers and improving overall effectiveness Over 60% of individuals aged 18-34 opt for contraceptive apps and smart devices for birth control management in 2023 Focus on User-Centric Solutions Customizable contraceptive options Increased satisfaction and compliance among users as they can select products that suit their preferences and lifestyle, leading to higher retention rates According to MMR analysis 25% increase in user satisfaction with contraceptive choices since the introduction of more personalized options Japan Contraceptive Devices Market Segment Analysis:
Based on Type, the Condoms segment held the largest market share of more than 45% and dominated the Japan Contraceptive Devices industry in 2023. The segment is further expected to grow at a CAGR of 7.8% and maintain its dominance during the forecast period. The shift towards textured and flavored condoms driven by a desire for enhanced pleasure is expected to be the major factor driving the segment's growth. The major players dominating the condom segments are Okamoto and LION, which are known for their thin, premium options. 1. As per the MMR analysis, 60% of people in the age group of 16-24 use condoms. 2. 10% of currently married women of reproductive age intend to use the pill when it comes on the market. 3. Japan has a contraceptive failure rate of about 25 percent, with 29 percent of women having had at least one abortion.Besides that, the Intrauterine Devices (IUDs) segment is expected to grow at a rapid CAGR and offer lucrative growth opportunities for Japan Contraceptives device manufacturers all across Japan during the forecast period. The growing demand is projected thanks to increasing awareness and healthcare professional recommendations drive continued expansion are expected to be the major factors driving the segment growth. The fastest growing segment thanks to high effectiveness, reversibility, and minimal user maintenance as major players are Fujifilm Healthcare’s Liletta IUD and Bayer’s Mirena IUD.• As per the MMR analysis, IUD usage among women in their 20s and 30s is potentially driven by their convenience and long-term efficacy.
The major key players in the Japan Contraceptive Devices Market are Merck & Co., Inc., Bayer AG, Pfizer Inc., Teva Pharmaceutical Industries Ltd, and MSD. Thus, increasing demand for the Japan Contraceptive Devices market supports the segment growth.Japan Contraceptive Devices Market Scope: Inquiry Before Buying
Japan Contraceptive Devices Market Report Coverage Details Base Year: 2023 Forecast Period: 2024-2030 Historical Data: 2018 to 2023 Market Size in 2023: US $ 845 Mn. Forecast Period 2024 to 2030 CAGR: 7.5% Market Size in 2030: US $ 1401.9 Mn. Segments Covered: by Type Condoms Diaphragms Cervical Caps Sponges Vaginal Rings Intra Uterine Devices (IUD) Other Devices by Gender Male Female Japan Contraceptive Devices Market Key Players:
1. Reckitt Benckiser 2. Cooper Surgical Inc. 3. Abbvie Inc (Allergan Plc) 4. Merck & Co., Inc, 5. Bayer Ag 6. Pfizer Inc 7. Teva Pharmaceutical Industries Ltd 8. Msd 9. Johnson & Johnson 10. Okamoto Industries, Inc 11. Fujifilm Healthcare Corporation 12. Lion Corporation 13. Sawai Pharmaceutical Co., Ltd 14. Zeria Pharmaceutical Co., LtdFAQ
1. What types of contraceptive devices are popular in Japan? Ans: In Japan, contraceptive devices such as condoms, intrauterine devices (IUDs), hormonal implants, and contraceptive patches are among the commonly used methods. However, there's a growing interest in long-acting reversible contraceptives (LARCs) like IUDs and hormonal implants due to their effectiveness and convenience. 2. What are the key factors influencing the adoption of contraceptive devices in Japan? Ans: Factors influencing adoption include cultural attitudes towards contraception, ease of use, efficacy, cost, privacy concerns, and accessibility. Additionally, shifts in societal norms and preferences impact the adoption of newer, more user-friendly devices. 3. What is the projected market size & and growth rate of the Japan Contraceptive Device Market? Ans. The Japan Contraceptive Device Market size was valued at USD 845 Million in 2023 and the total Japan Contraceptive Device revenue is expected to grow at a CAGR of 7.5% from 2023 to 2029, reaching nearly USD 1401.9 Million. 4. What segments are covered in the Japan Contraceptive Device Market report? Ans. The segments covered in the Japan Contraceptive Device market report are Type and Gender.
1. Japan Contraceptive Devices Market: Executive Summary 1.1. Overview Of The Report 1.2. Scope And Methodology 1.3. Overview Of Japan’s Healthcare System 1.4. Population Demographics And Contraceptive Behavior 1.5. Regulatory Framework For Contraceptive Devices In Japan 2. Japan Contraceptive Devices Market: Competitive Landscape 2.1. Mmr Competition Matrix 2.2. Competitive Landscape, Market Share, And Strategic Initiatives 2.3. Leading Market Players 2.3.1. Company Profiles 2.3.2. Product Portfolio 2.3.3. Market Strategies 2.4. Competitive Benchmarking 2.4.1. Swot Analysis And Comparative Assessment 2.5. Recent Mergers, Acquisitions, And Partnerships 2.6. Regulatory Landscape 2.6.1. Government Policies And Regulations 2.6.2. Impact On The Contraceptive Devices Market 2.7. Technological Advancements And Innovation 2.7.1. Recent Technological Developments 2.7.2. Market Adoption Of Advanced Contraceptive Solutions 2.8. Market Structure 2.8.1. Market Leaders 2.8.2. Market Followers 2.8.3. Emerging Players 2.9. Consolidation Of The Market 3. Japan Contraceptive Devices Market: Dynamics 3.1. Market Trends And Innovations 3.1.1. Technological Advancements 3.1.2. Emerging Trends In Contraceptive Devices 3.2. Market Drivers Shaping The Contraceptive Devices Market 3.3. Market Restraints And Challenges 3.4. Opportunities And Future Trends 3.5. Distribution Channels Analysis 3.5.1. Hospitals And Clinic Sales 3.5.1.1. Adoption Rates And Preferences 3.5.2. Retail Pharmacies And Online Platforms 3.5.2.1. Market Penetration And Consumer Behavior 3.6. Consumer Insights And Behavior 3.6.1. Understanding User Preferences 3.6.2. Factors Influencing Purchase Decisions 3.6.3. Awareness And Education Initiatives 3.7. Porter’s Five Forces Analysis 3.8. Pestle Analysis 4. Japan Contraceptive Devices Market Size And Forecast By Segments (By Value USD) 4.1. Japan Contraceptive Devices Market Size And Forecast, By Type (2023-2030) 4.1.1. Condoms 4.1.2. Diaphragms 4.1.3. Cervical Caps 4.1.4. Sponges 4.1.5. Vaginal Rings 4.1.6. Intra Uterine Devices (Iud) 4.1.7. Other Devices 4.2. Japan Contraceptive Devices Market Size And Forecast, By Gender (2023-2030) 4.2.1. Male 4.2.2. Female 5. Company Profile: Key Players 5.1. Reckitt Benckiser 5.1.1. Company Overview 5.1.2. Financial Overview 5.1.3. Business Portfolio 5.1.4. Swot Analysis 5.1.5. Business Strategy 5.1.6. Recent Developments 5.2. Cooper Surgical Inc. 5.3. Abbvie Inc (Allergan Plc) 5.4. Merck & Co., Inc, 5.5. Bayer Ag 5.6. Pfizer Inc 5.7. Teva Pharmaceutical Industries Ltd 5.8. Msd 5.9. Johnson & Johnson 5.10. Okamoto Industries, Inc 5.11. Fujifilm Healthcare Corporation 5.12. Lion Corporation 5.13. Sawai Pharmaceutical Co., Ltd 5.14. Zeria Pharmaceutical Co., Ltd 6. Key Findings 7. Japan Contraceptive Devices Market: Research Methodology 8. Industry Recommendation